The long journey to the isolation and characterization of MTHFD2 began with the identification by Scrimgeour and Huennekens in 1960 of a distinctive enzymatic activity (NAD+-dependent methylenetetrahydrofolate dehydrogenase activity) in Ehrlich ascite tumour cells. Here, MTHFD2 is linked to neoplasm.